Triglav Skladi’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.42M Hold
6,400
– – 0.07% 129
2026
Q2
$1.25M Hold
6,400
– – 0.07% 131
2026
Q1
$1.44M Hold
6,400
– – 0.1% 108
2025
Q4
$1.54M Sell
6,400
-1,000
-14% -$256K 0.1% 105
2025
Q3
$2.03M Hold
7,400
– – 0.13% 78
2025
Q2
$1.91M Hold
7,400
– – 0.14% 79
2025
Q1
$1.66M Hold
7,400
– – 0.14% 80
2024
Q4
$1.69M Hold
7,400
– – 0.13% 80

Other funds holding RMD

Triglav Skladi's RMD Position: Q3 2026 in Review

Triglav Skladi held its ResMed (RMD) position steady in Q3 2026 at 6,400 shares worth $1.42M. The position accounts for 0.07% of the portfolio, ranked #129.

Triglav Skladi first reported a position in RMD in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.03M in Q3 2025. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Triglav Skladi held 6,400 shares of ResMed worth $1.42M as of Q3 2026.
  • Triglav Skladi left its ResMed share count unchanged in Q3 2026.
  • ResMed made up 0.07% of Triglav Skladi's portfolio in Q3 2026, its #129 holding.
  • Triglav Skladi first reported a position in ResMed in Q4 2024 and has held it in 8 quarters since.
  • Triglav Skladi's ResMed position peaked at $2.03M in Q3 2025.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Triglav Skladi's 13F filing for Q3 2026, filed 6 Nov 2026.